Increased Vigilance by MINSA Against Rising Wave of Counterfeit and Substandard Drugs

Panama Issues Urgent Alert Over Counterfeit medications

Panama City, Panama – The Ministry of Health (MINSA) has issued a critical public health warning concerning the growing presence of counterfeit and substandard medications within the country. Health Minister Fernando Boyd Galindo emphasized that this is a serious threat, mirroring a global issue with potentially devastating consequences for patient safety.

National Campaign Launched to Combat Falsification

In response to the escalating risk, MINSA has initiated a national awareness campaign with the slogan “High. Not everything that seems to be health,denounces falsification and saves your life.” The campaign aims to educate citizens about the dangers of fraudulent medications and empower them to protect themselves.

Understanding the threat: Falsified vs. Substandard

Health officials clarified the distinction between falsified and substandard drugs. Falsified products are those with deliberately fraudulent representation of their identity, composition, or origin. Substandard medications, while originating from authorized manufacturers, fail to meet established quality standards. Both types pose significant risks to public health by compromising treatment effectiveness and potentially causing lethal outcomes.

Panama’s strategic position as a major logistics hub and its thriving commercial activity, coupled with the increasing prevalence of online commerce and informal distribution channels, contribute to the ease with which these risky products enter the country. This presents considerable challenges for surveillance and control efforts.

Operation Pangea and Collaborative Efforts

Authorities highlighted the importance of collaborative efforts in combating this issue. Uriel Pérez, the National Director of Pharmacies and Drugs at MINSA, praised the coordinated work of various institutions involved. He pointed to Operation Pangea XV, conducted from June 24 to June 30, 2022, which resulted in the seizure of 275,075 units of unregistered medicines valued at approximately 222,195 Balboas.

This large-scale operation involved the public force,the National Customs Authority,the Public Ministry,and MINSA,encompassing inspections of establishments,containers,and websites,and also the review of over 4,000 digital links,3,000 packages and 280 postal centers.

Key Strategies to Enhance medication Safety

To address this growing challenge, MINSA has outlined several key strategies:

• Strengthening surveillance and control measures, including increased inspections and enhanced collaboration with the National Customs Authority.
• Implementing traceability technologies, such as unique codes and digital platforms, to verify medication authenticity throughout the supply chain.
• Launching public awareness campaigns to discourage purchases from unauthorized sources, especially online platforms.
• Providing training to healthcare professionals to improve their ability to detect suspicious products and report adverse events.
• Strengthening international cooperation with organizations like the Pan American Health Organization (PAHO) and the World Health Organization (WHO) to share best practices and experiences.

Participants in the recent announcement included Rosa Buitrago del Rosal,Dean of the Faculty of Pharmacy at the University of Panama; Grisell Mojica,Superior Prosecutor of Legal Affairs; Alfredo Callejas,Director of Human Resources of the ministry of Security; and representatives from the National Customs Authority,the Technological University of Panama,the Attorney General’s office,and the National Police.

Type of Medication	characteristics	Potential Risks
Falsified	Deliberately fraudulent identity, composition, or origin.	Ineffective treatment, adverse reactions, potential toxicity.
Substandard	From authorized manufacturers but does not meet quality standards.	Reduced efficacy, unpredictable effects, possibility of harm.

The Global Rise of Counterfeit Drugs

The problem of counterfeit drugs is a global phenomenon, with the World Health Organization estimating that 10% of medical products in low- and middle-income countries are substandard or falsified. This issue not only threatens public health but also undermines confidence in healthcare systems. According to recent reports from the Interpol,the trade in counterfeit medicines generates billions of dollars annually,funding other forms of organized crime. The situation has been exacerbated by the COVID-19 pandemic, leading to a surge in the production and distribution of fake vaccines and treatments.

Did You know? Buying medications from unregulated online pharmacies significantly increases your risk of receiving counterfeit or substandard products.

Pro Tip: Always verify the authenticity of your medications with a pharmacist and ensure they are properly sealed and labeled.

Frequently Asked Questions About Counterfeit Drugs

What steps will you take to ensure the medications you are taking are legitimate? how concerned are you about the prevalence of counterfeit drugs in Panama?

Share your thoughts in the comments below.

What specific actions is MINSA taking to collaborate with the National Police in combating the circulation of counterfeit drugs?

The Growing Threat of Fake Medications in Panama

The Ministry of Health of Panama (MINSA) has substantially increased its surveillance and enforcement efforts to combat the escalating problem of counterfeit drugs and substandard pharmaceuticals circulating within the country. this surge in falsified medications poses a serious public health risk,impacting patient safety and eroding trust in the healthcare system. The term “counterfeit,” as defined by regulatory bodies,refers to deliberately mislabeled medicines,while “substandard drugs” are authorized medications that fail to meet quality standards.Both present significant dangers.

Recent MINSA Actions & Seizures

Over the past six months, MINSA has reported a marked increase in the number of seizures of fake medications, particularly in areas bordering Colombia and costa Rica. These operations, often conducted in collaboration with the National Police, have targeted:

Illegally imported drugs: Medications entering Panama without proper authorization or documentation.

Falsified packaging: Genuine drugs repackaged with counterfeit labels and data.

Substandard manufacturing: Drugs produced under conditions that do not meet Good Manufacturing Practices (GMP).

Online pharmacies: Unlicensed online vendors selling possibly dangerous medications.

Recent seizures have included large quantities of counterfeit antibiotics, analgesics, and even medications used to treat chronic conditions like hypertension and diabetes. The financial impact of these seizures is ample, but the potential harm to public health is far greater.

Identifying Counterfeit and Substandard Drugs: A Patient’s Guide

It can be arduous for patients to distinguish between genuine and fake drugs. MINSA recommends the following precautions:

1. Verify the Packaging: Look for inconsistencies in packaging, such as misspellings, poor print quality, or damaged seals.
2. Check the Expiration Date: Ensure the medication has not expired.
3. Inspect the Tablet/Capsule: Examine the appearance of the medication. Discoloration, unusual shapes, or inconsistencies in size can be red flags.
4. Purchase from Licensed Pharmacies: Always obtain medications from reputable, licensed pharmacies. Avoid purchasing drugs from street vendors or unregulated online sources.
5. be Wary of Significantly Lower prices: If a price seems too good to be true,it likely is. Counterfeit drugs are often sold at drastically reduced prices.
6. Report Suspicious Medications: If you suspect a medication is counterfeit,report it to MINSA instantly.

The Impact on Public Health & Healthcare Costs

The proliferation of substandard and falsified medicines has far-reaching consequences:

Treatment Failure: Counterfeit drugs may contain incorrect dosages or inactive ingredients, leading to treatment failure and worsening of health conditions.

Adverse Drug Reactions: Harmful substances found in fake medications can cause serious adverse reactions, including organ damage and even death.

Antimicrobial Resistance: The use of substandard antibiotics contributes to the growing problem of antimicrobial resistance, making infections harder to treat.

Increased Healthcare Costs: Treating complications arising from counterfeit drugs places a significant burden on the healthcare system.

Loss of Confidence: Erodes public trust in the pharmaceutical supply chain and healthcare providers.

MINSA’s Enhanced Strategies for Combating Falsification

MINSA is implementing a multi-pronged strategy to address this crisis:

Strengthened Border Controls: Increased inspections and surveillance at ports of entry to prevent the importation of counterfeit drugs.

Enhanced Pharmacy Inspections: More frequent and rigorous inspections of pharmacies to ensure compliance with regulations.

Public Awareness Campaigns: Educational initiatives to inform the public about the dangers of fake medications and how to identify them.

Collaboration with International Organizations: Working with organizations like the World Health Organization (WHO) and Interpol to share information and coordinate enforcement efforts.

Track and Trace Technology: Exploring the implementation of track and trace technologies to improve supply chain visibility and prevent the entry of counterfeit drugs.

Increased Penalties: Advocating for stricter penalties for those involved in the manufacturing and distribution of falsified pharmaceuticals.

Real-World Example: the 2022 Contaminated Insulin Case

In 2022, a case involving contaminated insulin highlighted the dangers of substandard drugs in Latin America. While not directly in Panama, the incident served as a stark warning. Several countries reported patients experiencing severe health complications after receiving insulin that did not meet quality standards. This prompted increased scrutiny of pharmaceutical supply chains throughout the region and reinforced the need for robust regulatory oversight.This event underscored the importance of verifying the authenticity of medications,particularly those used to manage chronic conditions.

Benefits of Increased MINSA Vigilance

The increased vigilance by MINSA offers several key benefits:

Improved Patient Safety: Protecting patients from the harmful effects of counterfeit and substandard drugs.

Enhanced Public Health: Reducing the spread of antimicrobial resistance and preventing outbreaks of drug-related illnesses.

Strengthened Healthcare System: Maintaining public trust in the pharmaceutical supply chain and healthcare providers.